Topics
View Supplement
Matthew Elitt, MD, PhD; Pariyamon Thaprawat, BS; and Nita Valikodath, MD, MS
Zhuojun Guo, MD, PhD; Ahmed Shakarchi, MD, MPH; and Sami Uwaydat, MD
Donald J. D’Amico, MD
November/December 2025 Insert
Editorially Independent Content supported by Genentech + Ocular Therapeutix
Editorially Independent Content, Supported With Advertising From Astellas
Editorially independent content, supported with advertising from Regeneron
Editorially independent supported by Abbvie and Regenxbio
November/December 2025 Supplement
Editorially independent content supported with advertising by Bausch + Lomb
Supplied and sponsored by Neurotech
Recent Supplements
Understanding Fast Progression in Geographic Atrophy
View Insert
Gaining Patients’ Buy-in With Geographic Atrophy Treatment: The Journey From Diagnosis to Long-term Adherence
Business Matters: When and How To Hire
Editorially independent content supported with advertising by EyePoint
One to Watch: Samir N. Patel, MD
Rising Stars in Retina: Prashant D. Tailor, MD
Signaling for Sustained Change: Spotlight on the Potential of TKIs to Deliver Durable Control of Exudative Retinal Disease
This activity is supported by an independent educational grant from EyePoint Pharmaceuticals.
View More
Eyetube Retina Series
EYETUBE RETINA MEETING COVERAGE